Recombinant Α-Actinin Subunit Antigens of Trichomonas Vaginalis As Potential Vaccine Candidates in Protecting Against Trichomoniasis.

Yi-Ting Xie,Jiang-Mei Gao,Ya-Ping Wu,Petrus Tang,Geoff Hide,De-Hua Lai,Zhao-Rong Lun
DOI: https://doi.org/10.1186/s13071-017-2009-8
2017-01-01
Parasites & Vectors
Abstract:Human trichomoniasis caused by Trichomonas vaginalis is one of the most common sexually transmitted diseases with more than 200 million cases worldwide. It has caused a series of health problems to patients. For prevention and control of infectious diseases, vaccines are usually considered as one of the most cost-efficient tools. However, until now, work on the development of T. vaginalis vaccines is still mainly focused on the screening of potential immunogens. Alpha-actinin characterized by high immunogenicity in T. vaginalis was suggested as a promising candidate. Therefore, the purpose of this study was to evaluate the protective potency of recombinant α-actinin against T. vaginalis infection in a mouse intraperitoneal model.
What problem does this paper attempt to address?